Literature DB >> 29055064

Clinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis.

Yu Liu1, Wenhui Wan1, Fang Fang1, Lei Guo1, Yusheng Zhao1, Xinghu Zhang1, Fang Huang1.   

Abstract

BACKGROUND: Peroxisome proliferator-activated receptor-γ (PPARγ) is a regulator of inflammation. This study aimed to explore associations between PPARγ gene single-nucleotide polymorphisms (SNPs) and susceptibility to and clinical outcome of sepsis in the North China Han population.
METHODS: This study included 303 patients with sepsis and 303 controls. We conducted genetic typing for 13 common PPARγ gene SNPs (improved multiplex ligation detection reaction), linkage disequilibrium mapping, and haplotype inference. Associations between SNP genotypes/haplotypes and sepsis susceptibility and outcome (septic shock, organ dysfunction, or death) were assessed using unconditional logistic regression analysis.
RESULTS: For rs2972164, patients with genotypes CT/CT+TT had higher risk of sepsis than genotype CC (odds ratio [95% CI]: 1.74 [1.05-2.86], P = .03 and 1.72 [1.06-2.80], P = .026, respectively); the T allele was associated with increased sepsis risk compared with the C allele (1.64 [1.04-2.58], P = .033). For rs1801282, genotypes CG/CG+GG had lower risk of sepsis than genotype CC (0.55 [0.33-0.92], P = .024 and 0.57 [0.35-0.95], P = .03, respectively); the G allele was associated with decreased sepsis risk compared with the C allele (0.62 [0.39-1.01], P = .055). For rs4135275, genotypes AG/AG+GG had higher risk of severe organ dysfunction (multiple organ dysfunction syndrome score >8) than genotype AA (2.66 [1.16-6.09], P = .038 and 2.21 [1.00-4.85], P = .042, respectively). Haplotype TAT (rs2972164, rs4684846, and rs17036188) was associated with increased sepsis risk (1.66 [1.03-2.67], P = .038).
CONCLUSIONS: No mutation was correlated with septic shock or death. PPARγ gene polymorphisms may play a role in the occurrence and progression of sepsis in the North China Han population.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  peroxisome proliferator-activated receptor gamma; polymorphism; prognosis; risk; sepsis; single nucleotide

Mesh:

Substances:

Year:  2017        PMID: 29055064      PMCID: PMC6817069          DOI: 10.1002/jcla.22340

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  40 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians.

Authors:  William Abbott; Edward Gane; Ingrid Winship; Stephen Munn; Colin Tukuitonga
Journal:  Immunogenetics       Date:  2007-01-09       Impact factor: 2.846

5.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

Authors:  Zi-Jiang Chen; Han Zhao; Lin He; Yuhua Shi; Yingying Qin; Yongyong Shi; Zhiqiang Li; Li You; Junli Zhao; Jiayin Liu; Xiaoyan Liang; Xiaoming Zhao; Junzhao Zhao; Yingpu Sun; Bo Zhang; Hong Jiang; Dongni Zhao; Yuehong Bian; Xuan Gao; Ling Geng; Yiran Li; Dongyi Zhu; Xiuqin Sun; Jin-E Xu; Cuifang Hao; Chun-E Ren; Yajie Zhang; Shiling Chen; Wei Zhang; Aijun Yang; Junhao Yan; Yuan Li; Jinlong Ma; Yueran Zhao
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

6.  Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors.

Authors:  M Barbieri; M R Rizzo; M Papa; R Acampora; L De Angelis; F Olivieri; F Marchegiani; C Franceschi; G Paolisso
Journal:  Exp Gerontol       Date:  2005-07       Impact factor: 4.032

Review 7.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

Authors:  J C Marshall; D J Cook; N V Christou; G R Bernard; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1995-10       Impact factor: 7.598

8.  PPARγ in Inflammatory Bowel Disease.

Authors:  Vito Annese; Francesca Rogai; Alessia Settesoldi; Siro Bagnoli
Journal:  PPAR Res       Date:  2012-09-10       Impact factor: 4.964

9.  The Pro12Ala Polymorphism of PPAR-γ Gene Is Associated with Sepsis Disease Severity and Outcome in Chinese Han Population.

Authors:  Guoda Ma; Haiyang Wang; Guixi Mo; Lili Cui; You Li; Yiming Shao; Xin Liu; Yuliu Xie; Jia Li; Jiawu Fu; Hua Tao; Bin Zhao; Liangqing Zhang; Keshen Li
Journal:  PPAR Res       Date:  2014-07-20       Impact factor: 4.964

Review 10.  Bench-to-bedside review: Association of genetic variation with sepsis.

Authors:  Ainsley M Sutherland; Keith R Walley
Journal:  Crit Care       Date:  2009-04-29       Impact factor: 9.097

View more
  1 in total

1.  Association between PPARG genetic polymorphisms and ischemic stroke risk in a northern Chinese Han population: a case-control study.

Authors:  Yan-Zhe Wang; He-Yu Zhang; Fang Liu; Lei Li; Shu-Min Deng; Zhi-Yi He
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.